Researcher comment: The FINCH 3 trial
Rene Westhovens summarizes the results of the FINCH 3 trial, which investigated filgotinib with and without methotrexate in rheumatoid arthritis patients with no prior methotrexate exposure (3:40).
- News story | Filgotinib beneficial for RA patients with no prior methotrexate exposure
- Expert commentary | WATCH: Roy Fleischmann discusses the FINCH 3 results
- Expert commentary | WATCH: John Isaacs discusses the FINCH 1 and FINCH 3 results